Christophe Michoud

USPTO Granted Patents = 15 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 48(Granted Patents)

Company Filing History:

12 out of 4,942

Hoffmann-la Roche Inc.

F. Hoffmann-la Roche Ag

patents

Years Active: 2000-2018

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 10053431 - Tetrahydro-benzodiazepinones (2018-08-21),

2. 9611224 - Antiproliferative benzo [B] azepin-2-ones (2017-04-04),

3. 9394263 - Substituted hetero-azepinones (2016-07-19),

4. 8962622 - Benzotriazole kinase modulators (2015-02-24),

5. 8404859 - Thiazole and thiophene compounds (2013-03-26),

6. 8399462 - JNK modulators (2013-03-19),

7. 7504513 - Thiazolyl-benzimidazoles (2009-03-17),

8. 7485752 - Diacylglycerol acyltransferase inhibitors (2009-02-03),

9. 7317125 - Diacylglycerol acyltransferase inhibitors (2008-01-08),

10. 7250515 - Thiazolinone 3,4-disubstituted quinolines (2007-07-31),

11. 7241893 - Thiazolinone 2-substituted quinolines (2007-07-10),

12. 7115740 - Pyrimido compounds having antiproliferative activity (2006-10-03),

13. 7084270 - Pyrimido compounds having antiproliferative activity (2006-08-01),

14. 6221867 - 4,5-pyrazinoxindoles (2001-04-24),

15. 6153634 - 4,5-azolo-oxindoles (2000-11-28),

Title: The Innovative Contributions of Christophe Michoud

Introduction

Christophe Michoud is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, Michoud has made remarkable strides in developing compounds aimed at treating serious health conditions, particularly cancer.

Latest Patents

Among his latest patents are the Tetrahydro-benzodiazepinones, which disclose compounds of Formula I, or pharmaceutically acceptable salts thereof. These compounds are described in detail within the application, along with methods for their use in cancer treatment. Another notable patent is for Antiproliferative benzo [B] azepin-2-ones, which also outlines compounds of Formula (I) and their potential applications in combating cancer.

Career Highlights

Throughout his career, Michoud has worked with esteemed companies such as Hoffmann-La Roche Inc. and Roche Palo Alto LLC. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Some of his notable coworkers include Kin-Chun Thomas Luk and Kenneth Carey Rupert. Their collaboration has likely fostered an environment of creativity and innovation, leading to the development of impactful pharmaceutical solutions.

Conclusion

Christophe Michoud's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical treatments, particularly in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

3 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.